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hospitals due to the multidrug resistance. Although antibiotic resistance has been well studied by traditional methods, there are few attempts at systems-wide investigations into how the bacteria respond to antibiotic stress using the state-of-art mass spectrometry-based proteomics. In this thesis, spectral counting-based label-free quantitative proteomics has been applied to study the global responses in S. aureus treated with antibiotics. Firstly, proteome responses of MRSA and methicillin-susceptible S. aureus (MSSA) to sub-inhibitory doses of oxacillin were studied. The results showed the systematic responses of the bacteria besides the known resistance mechanism: PBP2a and β-lactamase. Secondly, label-free quantitative proteomics was applied to study the responses of MRSA to a synergistic drug combination: a new erythromycin derivative SIPI-8294 and oxacillin, aiming at revealing the synergistic mechanism. The results showed that the synergistic mechanism might be related to the interference of the known oxacillin resistance mechanism, as well as the cell wall biosynthesis and oxidative-reductive homeostasis. Thirdly, in order to mimic the clinical situation in treating infection, a lethal dose of the combination SIPI-8294 and oxacillin was applied to MRSA cells, and the proteome responses were measured over time. The results revealed that the cellular responses were completely different under a lethal dose and a sub-inhibitory dose. The data obtained offered a more complete view of the cellular responses to antibiotics at different doses, and may be useful in guiding the development of new antibiotics or treatment strategies. 
